EFFECTS OF THE IMMUNOMODULATOR ‘GALAVIT’ ON THE DEVELOPMENT OF B16 MELANOMA IN MICE

EFFECTS OF THE IMMUNOMODULATOR ‘GALAVIT’ ON THE DEVELOPMENT OF B16 MELANOMA IN MICE

In recent years, major attention has been devoted to immunotherapy in oncology. Immunotherapy is a promising treatment approach targeted to inhibit tumor growth via stimulating the body’s antitumor immune response. Purpose. The study was aimed to investigate the relationship between melanoma grow...

Full description

Bibliographic Details
Main Authors:	Elena M. Yatsenko, Denis S. Baranovsky, Marianna D. Pronkevich, Elena V. Isaeva, Anna N. Smirnova, Vasiliy N. Petrov, Sergey A. Ivanov, Andrey D. Kaprin
Format:	Article
Language:	English
Published:	Science and Innovation Center Publishing House 2023-04-01
Series:	Siberian Journal of Life Sciences and Agriculture
Subjects:	f1-mouse b16-f10 melanoma immunomodulatory galavit macrophages survival rate metastases
Online Access:	http://discover-journal.ru/jour/index.php/sjlsa/article/view/792

Similar Items

Immunomodulating agent Galavit for the prevention of frequent acute respiratory viral infections after COVID-19: A review
by: Aleksandra G. Rosatkevich
Published: (2023-06-01)

Pharmacological body-wide and immunotropic effects of galavit in the treatment of patients with purulent-inflammatory diseases of various origins and allergization
by: Veronika A. Zemskova, et al.
Published: (2023-09-01)

Effectiveness and eligibility of immunomodulators in the treatment of chronic cervicitis
by: E. R. Dovletkhanova
Published: (2013-12-01)

Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
by: Rosa Fonti, et al.
Published: (2020-06-01)

Antibiotic resistance – a modern global health problem. The search for possible solutions in treating PID
by: O. I. Lisicyna, et al.
Published: (2018-09-01)

Giant adrenal metastasis of malignant melanoma: impact of 18F-FDG PET/CT in early assessment of dramatic response to immunotherapy: case report
by: Forough Kalantari, et al.
Published: (2023-09-01)

Immunomodulating medicine Galavit antitumor action research
by: L. I. Primushko, et al.
Published: (2007-03-01)

Zosteriform Cutaneous Distant Metastases as Onset of Relapsing Melanoma
by: Daniel Morgado-Carasco, et al.
Published: (2019-12-01)

STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
by: E. P. Turmova, et al.
Published: (2012-05-01)

USING IMMUNOMODULATING DRUG GALAVIT IN TREATMENT OF INFLUENZA
by: T. V. Sologub, et al.
Published: (2015-10-01)

EXPERIENCE IN USING SODIUM AMINODYHYDROPHTALAZINDIONE AS PART OF COMBINATION THERAPY OF DISPLATIC CHANGES OF THE UTERINE CERVIX EPITHELIUM ASSOCIATED WITH ACUTE SPECIFIC INFLAMMATION
by: Yu. E. Dobrokhotova, et al.
Published: (2018-01-01)

Metastatic Cutaneous Melanoma: A Rare Entity with a Unique Presentation
by: Manish Pradhan, et al.
Published: (2019-12-01)

Intraventricular metastatic melanoma: A rare case report
by: M.S. Cámara Marcos, et al.
Published: (2022-04-01)

Malignant melanoma with liver and spleen metastases: case report
by: Laura Cotta Ornellas, et al.
Published: (2000-03-01)

The Diagnosis and Management of Cutaneous Metastases from Melanoma
by: Cosimo Di Raimondo, et al.
Published: (2023-09-01)

Effect of Cordyceps sinensis on TIMP-1 secretion from mouse melanoma cell
by: Kubo Erika, et al.
Published: (2012-02-01)

Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies
by: Valeria Internò, et al.
Published: (2023-02-01)

SENTINEL LYMPH NODE BIOPSY IN PREVENTING REGIONAL RELAPSES IN PATIENTS WITH LOCALLY ADVANCED CUTANEOUS MELANOMA
by: D. V. Kudryavtsev, et al.
Published: (2017-12-01)

Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches
by: Claudio Tabolacci, et al.
Published: (2021-06-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01)

Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis
by: Hong Liu, et al.
Published: (2019-12-01)

Role and Place of PET/CT in the Assessment of Skin Melanoma Prevalence
by: M. V. Sorokina, et al.
Published: (2022-07-01)

Malignant melanoma - cutaneous metastases
by: Padmavathy L, et al.
Published: (2008-01-01)

Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis
by: Omar Abdel-Rahman
Published: (2018-02-01)

Diagnostic and Therapeutic Particularities of Symptomatic Melanoma Brain Metastases from Case Report to Literature Review
by: Adelaida Avino, et al.
Published: (2024-03-01)

Multichamber Involvement of Metastatic Cardiac Melanoma
by: Maria S. Bonou, et al.
Published: (2022-02-01)

Intrathymic Localization of Melanoma: A Brief Report of Two Cases and a Review of the Literature
by: Giorgio Cannone, et al.
Published: (2023-06-01)

Cyclin F Downregulation Affects Epithelial-Mesenchymal Transition Increasing Proliferation and Migration of the A-375 Melanoma Cell Line
by: Krajewski A, et al.
Published: (2020-12-01)

Treatment of Locoregional Recurrences of Skin Melanoma (a Clinical Case)
by: O. N. Ganusevich, et al.
Published: (2020-06-01)

Metastatic malignant melanoma of the uterus diagnosed by colposcopy
by: Živadinović Radomir, et al.
Published: (2016-01-01)

Experimental Investigation of Immunomodulator Galavit<sup>®</sup> Diffusion in a Model System
by: E. G. Kuznetsova, et al.
Published: (2020-02-01)

Pigmented melanoma cell migration study on murine syngeneic B16F10 melanoma cells or tissue transplantation models
by: Maria-Cristina Predoi, et al.
Published: (2019-10-01)

Extent of Groin Dissection in Melanoma: A Mixed-Methods, Population-Based Study of Practice Patterns and Outcomes
by: Suzana Küpper, et al.
Published: (2021-12-01)

Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit
by: Anna M. Rose, et al.
Published: (2017-06-01)

Melanoma in situ with in-transit metastases
by: Joachim Mikkelsen, et al.
Published: (2017-03-01)

Visual agnosia and prosopagnosia secondary to melanoma metástases: Case report
by: Norberto Anízio Ferreira Frota, et al.

Increased HOX C13 expression in metastatic melanoma progression
by: Cantile Monica, et al.
Published: (2012-05-01)

The clinical and histopathological features of patients with both uveal and cutaneous melanoma
by: Anelise Savaris Dias, et al.
Published: (2020-01-01)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
by: Alexander Z. Wei, et al.
Published: (2022-09-01)

New possibilities of complex ttreatment of cervical ectropion
by: N. F. Khvorostukhina, et al.
Published: (2021-10-01)